Effect of haloperidol on dopamine-induced increase in renal blood flowARMSTRONG, D. K; DASTA, J. F; REILLEY, T. E et al.Drug intelligence & clinical pharmacy. 1986, Vol 20, Num 7-8, pp 543-546, issn 0012-6578Article

[³H]SCH 23390 binding sites increase after chronic blockade of D-1 dopamine receptorsPORCEDDU, M. L; ONGINI, E; BIGGIO, G et al.European journal of pharmacology. 1985, Vol 118, Num 3, pp 367-370, issn 0014-2999Article

BRL 20596, a novel anilide with central dopamine antagonist activityCAMPBELL, W; CLARK, M. S. G; MITCHELL, P. J et al.Psychopharmacologia. 1986, Vol 89, Num 2, pp 208-215, issn 0033-3158Article

Bilateral ballistic movements occuring as a late complication of hemispherectomy and responding to sulpirideWROE, S; RICHENS, A; COMPSTON, A et al.Journal of neurology. 1986, Vol 233, Num 5, pp 315-316, issn 0340-5354Article

Antipsychotic effect of remoxipride, a new substituted benzamide with selective antidopaminergic activityLAURSEN, A. L; GERLACH, J.Acta psychiatrica Scandinavica. 1986, Vol 73, Num 1, pp 17-21, issn 0001-690XArticle

Remoxipride in the treatment of acute maniaCHOUINARD, G; STEINER, W.Biological psychiatry (1969). 1986, Vol 21, Num 14, pp 1429-1433, issn 0006-3223Article

Modulatory role for prolactin in the elevation of striatal dopamine receptor density induced by chronic treatment with dopamine receptor antagonistsHRUSKA, R. E.Brain research bulletin. 1986, Vol 16, Num 3, pp 331-339, issn 0361-9230Article

Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and several of its analogues on the dopaminergic nigrostriatal pathway in miceHEIKKILA, R. E; MANZINO, L; CABBAT, F. S et al.Neuroscience letters. 1985, Vol 58, Num 1, pp 133-137, issn 0304-3940Article

High-performance liquid chromatographic determination of a new benzamide in biological fluids for use in a human pharmacokinetic studyBRESSOLLE, F; BRES, J; SNOUSSI, M et al.Journal of chromatography. 1985, Vol 343, Num 2, pp 443-448, issn 0021-9673Article

Postoperative neurologic dysfunction associated with preoperative administration of metoclopramideSCHELLER, M. S; SEARS, K. L.Anesthesia and analgesia. 1987, Vol 66, Num 3, pp 274-276, issn 0003-2999Article

Analgesic effect of metoclopramide and its mechanismRAMASWAMY, S; BAPNA, J. S.Life sciences (1973). 1986, Vol 38, Num 14, pp 1289-1292, issn 0024-3205Article

Different effects of metoclopramide and domperidone on arginine-vasopressin secretion in manCHIODERA, P; VOLPI, R; DELSIGNORE, R et al.British journal of clinical pharmacology. 1986, Vol 22, Num 4, pp 479-482, issn 0306-5251Article

A novel long-lasting dopamine receptor blocker: haloperidol-bovine serum albumin conjugateGARRIGUES, A.-M; STINUS, L; TAGHZOUTI, K et al.European journal of pharmacology. 1985, Vol 118, Num 3, pp 313-319, issn 0014-2999Article

Pharmacology in vivo of the phenylindan derivative, Lu 19-005, a new potent inhibitor of dopamine, noradrenaline and 5-hydroxytryptamine uptake in rat brainARNT, J; CHRISTENSEN, A. V; HYTTEL, J et al.Naunyn-Schmiedeberg's archives of pharmacology. 1985, Vol 329, Num 2, pp 101-107, issn 0028-1298Article

Potential uses for metoclopramideSHAUGHNESSY, A. F.Drug intelligence & clinical pharmacy. 1985, Vol 19, Num 10, pp 723-728, issn 0012-6578Article

The clinical significance of halopemide, a dopamine-blocker related to the butyrophenonesDE CUYPER, H; VAN PRAAG, H. M; VERSTRAETEN, D et al.Neuropsychobiology. 1984, Vol 12, Num 4, pp 211-216, issn 0302-282XArticle

Effects of dopaminergic agonists and antagonists on the partially contracted, isolated and perfused renal artery of the ratRODRIGUEZ-MENDEZ, S. A; FERIA, M; BOADA, J et al.Pharmacology. 1986, Vol 32, Num 6, pp 321-325, issn 0031-7012Article

GBR 12783, a potent and selective inhibitor of dopamine uptake: biochemical studies in vivo and ex vivoBONNET, J.-J; COSTENTIN, J.European journal of pharmacology. 1986, Vol 121, Num 2, pp 199-209, issn 0014-2999Article

Interaction of buspirone and dopaminergic agents on punished behavior of pigeonsWITKIN, J. M; BARRETT, J. E.Pharmacology, biochemistry and behavior. 1986, Vol 24, Num 3, pp 751-756, issn 0091-3057Article

Specific binding of ³H-SCH 23390 to dopamine D1 receptors in vivoANDERSEN, P. H; GRONVALD, F. C.Life sciences (1973). 1986, Vol 38, Num 16, pp 1507-1514, issn 0024-3205Article

D-1 and D-2 dopamine receptor blockade: interactive effects in vitro and in vivoSALLER, C. F; SALAMA, A. I.The Journal of pharmacology and experimental therapeutics. 1986, Vol 236, Num 3, pp 714-720, issn 0022-3565Article

Dopamine receptor blockade does not affect the natriuresis accompanying sodium chloride infusion in dogsBRADLEY, T; GEWERTZ, B. L; SCOTT, W. J et al.The Journal of laboratory and clinical medicine. 1986, Vol 107, Num 6, pp 525-528, issn 0022-2143Article

Effect of pimozide on home cage ethanol drinking in the rat: dependence on drinking session lengthPFEFFER, A. O; SAMSON, H. H.Drug and alcohol dependence. 1986, Vol 17, Num 1, pp 47-55, issn 0376-8716Article

Influence of SCH 23390, a DA₁-receptor antagonist, on the behavioural responsiveness to small and large doses of apomorphine in ratsCUOMO, V; CAGIANO, R; COLONNA, M et al.Neuropharmacology. 1986, Vol 25, Num 11, pp 1297-1300, issn 0028-3908Article

Molecular electrostatic potential of orthopramides: implications for their interaction with the D-2 dopamine receptorVAN DE WATERBEEMD, H; CARRUPT, P.-A; TESTA, B et al.Journal of medicinal chemistry (Print). 1986, Vol 29, Num 5, pp 600-606, issn 0022-2623Article